This federal Project Grant award of $249,108 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research into the relationship between cannabis use, trauma, and self-regulatory cognitive processes in emerging adults. The project will recruit 70 participants from a parent study to assess how disruptions to reward motivation and inhibitory control following a potentially traumatic event relate to cannabis use patterns and...
This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), provides $594,099 to Brown University to characterize young adult dual users of marijuana and tobacco using novel behavioral economic measures. The 4-year project aims to better understand the behavioral mechanisms underlying this prevalent and risky pattern of substance use, which is associated with increased cancer risk across the lifespan. Key objectives...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $407,812 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the University of Oregon. The grant, titled "Dynamic Associations Between Impulsivity, Craving, and Co-Use of Alcohol, Cannabis, and Nicotine Among Young Adults", aims to collect intensive, momentary data from 250 young adults reporting tri-use of alcohol, cannabis, and nicotine. The research will examine the additive effects of cannabis...
This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) to the Cambridge Public Health Commission, doing business as the Cambridge Health Alliance, will provide $177,110 to study the impact of cannabis legalization and commercialization on substance use and mental health outcomes among individuals with psychosis. The research will utilize quasi-experimental difference-in-difference methods to analyze data from the Population...
This federal Project Grant award of $787,154.00 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will fund a research study on mental and behavioral health outcomes among bisexual adolescents and young adults (AYA) in the United States. The study aims to: 1) examine how sexual orientation-based stigma is experienced by bisexual AYA, 2) investigate the...
This four-year, $4.6 million project grant from the National Institute on Drug Abuse will fund research at the University of Miami exploring the linkage between cannabis use, route of administration, cannabinoid content, and measures of cardiovascular disease (CVD) risk in people living with HIV (PWH). Specifically, the principal investigator - an interventional cardiologist and physician scientist focused on HIV and CVD prevention - will collect comprehensive data on 300 PWH ages 18-60 to...
This federal Project Grant award of $703,457.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a longitudinal study to investigate the relationship between adolescent social media use and substance use. The study, led by the University of California, San Francisco, aims to: Determine the longitudinal associations and sensitive developmental windows linking social media use with substance use, including cannabis,...
This Project Grant award of $489,500, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to evaluate remote oral fluid testing as a method to assess cannabis non-use in clinical trials with young adults aged 18-30 years. The award, effective June 1, 2025 through May 31, 2027, will be performed by The Children's Hospital Corporation (Boston Children's Hospital), a non-profit pediatric medical research...
This Project Grant award, with a total funding amount of $957,600.00, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will be used by Drexel University to develop a novel framework for community-directed research approaches that seek to reduce intersectional and intergenerational inequities in commercial tobacco use among Black and Latinx adult sexual and gender minorities in Philadelphia. Key activities...
ECOLOGICAL MOMENTARY ASSESSMENT OF DAILY MINORITY STRESSORS AND CANNABIS AND TOBACCO CO-USE AMONG SEXUAL MINORITY YOUNG ADULTS - PROJECT SUMMARY PAST-MONTH CANNABIS USE AND TOBACCO USE, INDEPENDENTLY, IS 2 TIMES HIGHER IN SEXUAL MINORITY YOUNG ADULTS (SMYAS) (DEFINED HERE AS LESBIAN, GAY, QUEER, BISEXUAL/BISEXUAL+3) COMPARED TO THEIR HETEROSEXUAL PEERS.4 YOUNG ADULTHOOD IS A VULNERABLE PERIOD FOR SUBSTANCE USE INITIATION AND PROGRESSION5-7, COMING OUT8, 9, AND EXPERIENCING SEXUAL ORIENTATION DISCRIMINATION.10 IN FACT, NEARLY 1 IN 6 YOUNG ADULTS (YAS) IDENTIFIES AS A SEXUAL MINORITY (SM). BISEXUAL AND BISEXUAL+ (BI/BI+) IDENTITY IS THE MOST COMMON AND FASTEST GROWING GROUP OF ALL SM IDENTITIES,11 AND INDIVIDUALS WHO IDENTIFY AS BI/BI+ ARE AT GREATEST RISK FOR TOBACCO AND CANNABIS USE, INDEPENDENTLY, RELATIVE TO BOTH HETEROSEXUAL AND GAY/LESBIAN INDIVIDUALS.12,13 CANNABIS AND TOBACCO CO-USE (REFERRED TO AS CAN-TOB CO-USE) HAS BECOME INCREASINGLY POPULAR IN THE GENERAL POPULATION14-20, PARTICULARLY AMONG YOUNG ADULTS (YAS), YET LITTLE IS KNOWN ABOUT CAN-TOB CO-USE IN SMYAS.21 THIS IS CONCERNING, AS CAN-TOB CO-USE IS CORRELATED WITH GREATER CANNABIS AND NICOTINE DEPENDENCE,22, 23 POORER TOBACCO AND CANNABIS CESSATION OUTCOMES,24, 25 AS WELL AS SUBSTANCE USE AND MENTAL HEALTH PROBLEMS,6, 26-31 RELATIVE TO SINGLE USE OF EITHER. THE POPULARITY OF NON-CIGARETTE TOBACCO PRODUCTS (E-CIGARETTES, CIGARS, ETC.) AMONG SMYAS IS ALSO CONCERNING, AS THESE CAN BE USED AS VEHICLES TO CONSUME CANNABIS.32-35 MINORITY STRESS THEORY36 INDICATES THAT COPING WITH SEXUAL MINORITY STRESSORS (E.G., EXPERIENCES OF DISCRIMINATION) IS AN IMPORTANT REASON FOR SUBSTANCE USE AMONG SM INDIVIDUALS.36, 37 CANNABIS USE HAS BEEN ASSOCIATED WITH MOOD ENHANCEMENT AND TENSION-REDUCTION, AND MAY BE PARTICULARLY APPEALING TO SMYAS AS A MEANS TO COPE WITH MINORITY STRESS EXPERIENCES. CERTAIN PATTERNS OF CAN-TOB CO-USE, LIKE BLUNT SMOKING, WHICH RESULT IN AN INTENSE HIGH38, 39, MAY APPRECIABLY TEMPER OR MITIGATE THE NEGATIVE MENTAL AND EMOTIONAL IMPACTS OF DAILY AND "IN THE MOMENT" MINORITY STRESSORS, AND ENCOURAGE FUTURE USE OF CANNABIS OR OTHER SUBSTANCES, PLACING SM INDIVIDUALS AT GREATER RISK FOR NEGATIVE CONSEQUENCES.40 LITTLE DATA EXIST ON DAY-TO-DAY AND "IN THE MOMENT" MINORITY STRESSORS AND HOW THEY ARE CORRELATED WITH DIFFERENT PATTERNS OF CAN-TOB CO-USE AND SINGLE USE AMONG SMYAS. THIS PROPOSAL ADDRESSES THIS GAP BY SEEKING TO CHARACTERIZE DIFFERENT MINORITY STRESSORS AMONG SMYAS AND EXAMINE THEIR ASSOCIATIONS TO DAILY PATTERNS OF CAN-TOB CO-USE AND SINGLE USE, IN A SAMPLE OF 150 SMYAS (AGES 18-25) WHO ARE CURRENT TOBACCO USERS AND CONSUME CANNABIS > 2 A WEEK. IT IS RESPONSIVE TO NOT-OD-22-166 (RESEARCH ON THE HEALTH OF BISEXUAL AND BISEXUAL+ PEOPLE). PARTICIPANTS WILL TRACK CAN-TOB SINGLE USE AND CO-USE AS WELL AS "IN THE MOMENT" MINORITY STRESSORS (E.G., DAILY EXPERIENCES OF DISCRIMINATION) TWICE DAILY FOR 28 DAYS VIA ECOLOGICAL MOMENTARY ASSESSMENT (EMA). WE WILL CHARACTERIZE PATTERNS OF CAN-TOB SINGLE USE AND CO-USE AND ASSESS THE INDIRECT ASSOCIATION OF DAILY MINORITY STRESSORS ON THE ASSOCIATION OF SEXUAL ORIENTATION (BI/BI+ VS. MONOSEXUAL) WITH THESE PATTERNS OF USE. FINDINGS WILL INFORM THE DEVELOPMENT OF A FUTURE "JUST IN TIME" INTERVENTION DESIGNED TO TARGET RESPONSES TO MINORITY STRESS EXPERIENCES IN "REAL TIME" TO REDUCE CAN-TOB SINGLE USE AND CO-USE AMONG SMYAS. THE LONGER- TERM GOAL OF THIS PROPOSAL IS TO IDENTIFY THE BEHAVIORAL MECHANISMS CONTRIBUTING TO SUBSTANCE USE DISPARITIES IN SM INDIVIDUALS AND TO EVALUATE FEASIBLE INTERVENTION TARGETS TO REDUCE HEALTH DISPARITIES ACROSS SUB-GROUPS OF SM PEOPLE.